Filing Details

Accession Number:
0001439222-21-000031
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-16 16:14:21
Reporting Period:
2021-03-01
Accepted Time:
2021-03-16 16:14:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439222 Agios Pharmaceuticals Inc. AGIO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1840076 Darrin Miles C/O Agios Pharmaceuticals Inc.
88 Sidney Street
Cambridge MA 02139
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-01 2,200 $47.99 11,171 No 4 S Direct
Common Stock Disposition 2021-03-05 500 $48.58 10,671 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Includes 314 shares purchased through the Company's employee stock purchase plan.